Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer—Y90 and Chemoembolization

    loading  Checking for direct PDF access through Ovid

Abstract

Colorectal cancer is the third most common cancer in the United States and the liver is the most common site of metastatic disease. The presence and extent of hepatic metastases are a major prognostic indicator. Although surgical resection is the accepted first-line therapy for colorectal liver metastasis, only 20 to 25% of patients are eligible for resection due to the extent and location of disease. This article discusses the current role of transarterial therapies in the treatment of colorectal liver metastases.

Related Topics

    loading  Loading Related Articles